MyBiotics announces successful completion of the Phase 1 trial for its MBX-SD-202 whole microbiome treatment
Jan 24, 2022 – MyBiotics announces successful completion of the Phase 1 trial for its MBX–SD-202 whole microbiome treatment, driving an innovative path to new restoration therapies [...]
